Search clinical trials for: Antithrombin III

Total 10442 results

University of California, Irvine

Enrolling by invitation

Energy Devices for Rejuvenation

Rejuvenation

United States
Taner OZTURK, DDS, MS

Completed

The Effect of Orthopedic Face Mask Use on Head Posture and Pharyngeal Airway

Class III Malocclusion | Hyoid Bone

Turkey
British Columbia Cancer Agency

Completed

High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule (Dosepainting)

Prostate Cancer

Canada
Genentech, Inc.

Completed

A Study to Evaluate the Effect of Particle Size, Formulation and Food on the Pharmacokinetics of GDC-0032 in Healthy Volunteers

Healthy Volunteer

United States
University of Brasilia

Completed

Isokinetic Testing Protocol in Elderly and Young Men

Healthy

Brazil
Brigham and Women's Hospital

Completed

Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism

United States
Ural State Medical University
Boehringer Ingelheim

Unknown

Evaluation of Abbreviated Versus Conventional Course of Dabigatran Etexilate Before Electric Cardioversion in Patients With Atrial Fibrillation (RE-SOUND Study) (RE-SOUND)

Atrial Fibrillation

Russian Federation
Boehringer Ingelheim

Completed

Safety and Tolerability of Dabigatran Etexilate in Adolescents

Venous Thromboembolism

Canada
Boehringer Ingelheim

Completed

Bioequivalence of Two Different Capsule Types of Dabigatran

Healthy

Germany
Boehringer Ingelheim

Terminated

Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048

Stroke | Atrial Fibrillation

United States, Denmark, Netherlands, Sweden
Cukurova University

Unknown

Prevention of Hyperalgesia With Epidural Morphine

Hyperalgesia

Turkey
American Regent, Inc.

Completed

Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments

Restless Legs Syndrome
Children's Hospital Los Angeles
Baylor College of Medicine; Children's Hospital of Philadelphia; Children's Hospital... and other collaborators

Completed

The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids (UNBLOCK)

Deep Venous Thrombosis

United States
Brigham and Women's Hospital

Completed

Replication of the RELY Anticoagulant Trial in Healthcare Claims Data

Atrial Fibrillation

United States
University of Alberta
Boehringer Ingelheim

Completed

Canadian Pradaxa Acute Stroke Safety Study (CPASS)

Stroke | Ischemic Attack, Transient

Canada
Lawson Health Research Institute
Boehringer Ingelheim

Completed

DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation (DAPPARAF)

Atrial Fibrillation

Canada
Nycomed

Completed

ImproveR International (BI-001-IM)

Thrombin-specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI)

Denmark
Istanbul University

Recruiting

Postoperative Cognitive Dysfunction in Elderly Urologic Oncology Patients (POCD) (POCD)

Postoperative Delirium | Postoperative Cognitive Dysfunction | Frailty

Turkey
Boehringer Ingelheim

Completed

Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan

Non-alcoholic Fatty Liver Disease

Japan
Assistance Publique - Hôpitaux de Paris

Recruiting

Effect of a Self-hypnosis on Attention Disorders and Anxiety in Children With Attention Deficit/Hyperactivity Disorder (HYPNAAX)

Attention Deficit/Hyperactivity Disorder

France
Beth Israel Deaconess Medical Center
Opsens, Inc.

Recruiting

Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI (REFINE PCI)

Coronary Artery Disease

United States
University of Lausanne Hospitals

Completed

Comparison of Synchrony Between 4 NIV Ventilators

Respiratoy Failure Requiring NIV Treatment

Switzerland
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients (Thrombosis)

Cancer | Catheter Complications | Thrombosis, Venous

China
Daiichi Sankyo
Daiichi Sankyo Korea Co., Ltd.

Recruiting

A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation (SILVERCARE_AF)

Atrial Fibrillation

Korea, Republic of
University Hospital, Tours

Not yet recruiting

Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients (CARD-AXA)

Chronic Hemodialysis Patients
Mayo Clinic
Ottawa Heart Institute Research Corporation

Recruiting

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion (CAPITAL-RAPTOR)

Radial Artery Occlusion

United States
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Apixaban

Obesity, Morbid

Norway
Bayer

Completed

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Atrial Fibrillation | Prevention of Thromboembolic Events

United States
Daiichi Sankyo, Inc.
Daiichi Sankyo (China) Holdings Co., Ltd.

Active, not recruiting

Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China (ETNA-AF-CHINA)

Non-valvular Atrial Fibrillation

China
The Medicines Company

Withdrawn

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

Heparin-Induced Thrombocytopenia | Heparin-induced Thrombocytopenia and Thrombosis Syndrome

United States
LiuZhou People's Hospital

Unknown

Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports

Cancer | Rivaroxaban | Thromboprophylaxis
Prof. Stavros Konstantinides, MD
European Georges Pompidou Hospital

Terminated

Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism. (PEITHO-2)

Pulmonary Embolism

Germany
The Medicines Company

Completed

Bivalirudin as a Procedural Anticoagulant in Pediatrics

Cardiology
The Medicines Company

Completed

Study Of Angiomax In Infants Under Six Months With Thrombosis

Thrombosis

United States
Ionis Pharmaceuticals, Inc.

Completed

Safety, Tolerability, and Pharmacokinetic Study of ISIS ApoC-III Rx in Hypertriglyceridemia

Hypertriglyceridemia

United States, Canada
Hospital Avicenne

Terminated

Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation (SISCA)

CORONARY DISEASE

France
Seoul National University Hospital
Medtronic Korea Co., Ltd.; Samjin Pharmaceutical Co., Ltd.

Recruiting

Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation (POCKET-OAC)

Atrial Fibrillation

Korea, Republic of
J.P.S Henriques

Not yet recruiting

Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention (IMPACT AF-PCI)

Coronary Artery Disease | Atrial Fibrillation
China National Center for Cardiovascular Diseases
Chinese Academy of Medical Sciences, Fuwai Hospital

Recruiting

Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation

Non-Valvular Atrial Fibrillation

China
Shanghai Zhongshan Hospital

Recruiting

Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis

Venous Thrombosis

China
Irina Ermolaeva

Recruiting

RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD (RE-ELECT)

Chronic Kidney Diseases | Atrial Fibrillation | T2DM (Type 2 Diabetes Mellitus)

Russian Federation
Second Affiliated Hospital, School of Medicine,...
Bayer; The Central Hospital of Lishui City; Shaoxing People's Hospital; Wenzhou... and other collaborators

Recruiting

Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban

Intracranial Hemorrhages | Anticoagulant | Cerebrovascular Stroke | Matrix Metalloproteinases

China
Portola Pharmaceuticals
Merck Sharp & Dohme LLC

Completed

A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment

Renal Impairment

Germany
Daiichi Sankyo, Inc.
Daiichi Sankyo Deutschland GmbH

Completed

Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ENCOURAGE-AF)

Non-valvular Atrial Fibrillation

Germany
Daiichi Sankyo Turkey, a Daiichi Sankyo Company
Daiichi Sankyo, Inc.

Completed

Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (ETAF-TR)

Atrial Fibrillation

Turkey
Boehringer Ingelheim

Completed

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

Atrial Fibrillation

Japan
Daiichi Sankyo, Inc.
Quintiles, Inc.

Completed

Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes

Atrial Fibrillation

Denmark, Hungary, Croatia, Serbia, Spain, Russian Federation, Bulgaria, Latvia, Czechia, Poland, Estonia, Belgium, Lithuania, Slovakia, Ukraine
Boehringer Ingelheim

Completed

BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery

Venous Thromboembolism
Boehringer Ingelheim

Completed

Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function

Atrial Fibrillation

United States
Bristol-Myers Squibb

Completed

Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on Hemodialysis

End Stage Renal Disease

United States

Search clinical trials for: Antithrombin III

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations